Skip to content

Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa

Phase 1/2 Study of the Effect of TOT or Solifenacin After Cesa or Vasa on Urge Urinary Incontinence

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01737918
Acronym
URGE-II
Enrollment
120
Registered
2012-11-30
Start date
2013-01-31
Completion date
2018-07-31
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Treatment of Urge Incontinence

Keywords

urge urinary incontinence, cesa, vasa, TOT, solifenacin

Brief summary

Urge urinary incontinence can be a disorder caused by destroyed pelvic structures. We repaired the uteri-sacral ligaments (USL) by cesa or vasa. The study evaluates if solifenacin can lead to continence after surgery or if also the pubo-urethral ligaments (PUL) need to be repaired.

Detailed description

It was hypothesized that urge urinary incontinence in women is based on the destruction of the uteri-sacral ligaments (USL)and the pubourethral ligaments (PUL). In a preliminary study (URGE I) we repaired the USL by cesa or vasa. Those patients who are still incontinent after cesa and vasa get the repair of the PUL by means of trans-obturator tapes (TOT). That treatment is compared to conservative medical treatment. Cross over after completion of three months is possible if no continence is achieved.

Interventions

PROCEDURETOT
DRUGsolifenacin

Sponsors

Klinikum der Universität Köln
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* prior vasa or cesa operation as part of the URGE I study * stress urinary incontinence * mixed urinary incontinence

Exclusion criteria

* previous urogynecological surgery * avulsion of cesa or vasa tape * pregnancy * neurologic/psychological reasons for incontinence * body weight \>100kg * syndrome of dry overactive bladder

Design outcomes

Primary

MeasureTime frame
cure of incontinence3 months

Secondary

MeasureTime frame
improvement of urge symptoms3 months

Countries

Germany

Contacts

Primary ContactWolfram H Jager, PhD
wolfram.jaeger@uk-koeln.de0049221478
Backup ContactPeter Mallmann, PhD
peter.mallmann@uk-koeln.de0049221478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026